Le Lézard
Classified in: Science and technology, Business
Subject: PDT

Introducing a New Approach to Fund Accounting with Ark's Latest Innovation


Ark Pioneers Innovative Solutions to Meet the Needs of Private Capital Managers and Fund Administrators

BOSTON, April 16, 2024 /PRNewswire/ -- Ark is excited to announce the introduction of its latest breakthrough in fund management technology: a comprehensive fund accounting solution designed to revolutionize the way private funds operate. Moving beyond the traditional constraints of general ledger systems, Ark's new platform is engineered to address the intricate demands of partnership accounting, providing a seamless, integrated approach to managing private fund operations and investor relations with unparalleled precision and ease.

While off-the-shelf ledgers remain in wide use today because they can handle the basics, their inability to cater to the nuanced requirements of fund managers has led to reliance on cumbersome spreadsheets and manual reconciliations. Ark's new fund accounting capabilities transcend these limitations, combining ease of use with sophisticated automation, enabling fund operations teams to achieve the next level of efficiency.

Clients favor Ark's flexibility to easily handle data from third party platforms and fit seamlessly into their existing technology stack. While Ark will continue to support integrations with third-party ledger technology, the introduction of arkGL represents a significant milestone. Funds currently on other ledger solutions now have a new alternative available, and one built specifically to meet their unique accounting and investor reporting requirements.

"With no implementation fees, fast and configurable setup, and multi-manager engagement on a single screen, we are the most dynamic and scalable operating platform for venture capital and private equity managers," said Bill Ward, CEO of Ark. "We distill best practices from top fund services firms and GPs into a nimble and thoughtfully designed product." Ark's commitment to innovation and excellence in fund management is demonstrated through their pioneering fund accounting solution, further elevating the operational capabilities of private fund managers to new heights.

About Ark 

Ark is a leading cloud-based platform designed to optimize fund operations and automate investor reporting. Trusted by premier fund administrators and GP fund managers across the private capital markets, Ark currently supports over $125 billion in capital commitments, 70,000 end users, and 400 fund managers with SOC 2 Type II certification. Founded in Boston in 2017, our team leverages extensive experience in fund operations and financial technology to serve clients nationwide. For more information visit https://www.arkpes.com/fund-accounting/.

Contact: Chris Gale, [email protected]

SOURCE Ark PES


These press releases may also interest you

at 19:04
X Financial (the "Company"), a leading online personal finance company in China, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission ("SEC") on April 29,...

at 19:00
CEAT Specialty hosted the Achievers Meet 2024, aimed to fortify bonds with Australian channel partners, featuring an immersive IPL match experience at Delhi's Arun Jaitley Stadium. Amidst the charged atmosphere on April 27th, attendees witnessed the...

at 18:55
Voxtur Analytics Corp. ("Voxtur" or the "Company"), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today announced its financial results for the three months and year ended December 31,...

at 18:45
Pfizer Inc. and Genmab A/S today announced the U.S. Food and Drug Administration (FDA) approves the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with...

at 18:45
Genmab A/S and Pfizer Inc. announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for TIVDAK® (tisotumab vedotin-tftv) for the treatment of patients with recurrent or...

at 18:45
Pond Technologies Holdings Inc. (the "Corporation" or "Pond")  announces the filing of the audited consolidated financial statements of the Corporation for the twelve months ended December 31, 2023 and the related management's discussion and analysis...



News published on and distributed by: